4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-054517
Director sold 27,669 shares at an average $29.50 ($816,352)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT Director | 2021-08-31 | Sale | −177 | $29.43 | $5,209 | 259,975 | D: show line 1 in the form |
| GADICKE ANSBERT Director | 2021-08-31 | Sale | −1,285 | $29.43 | $37,818 | 7,759,840 | I: show line 2 in the form |
| GADICKE ANSBERT Director | 2021-08-31 | Sale | −215 | $30.14 | $6,480 | 259,760 | D: show line 3 in the form |
| GADICKE ANSBERT Director | 2021-08-31 | Sale | −1,553 | $30.14 | $46,807 | 7,758,287 | I: show line 4 in the form |
| GADICKE ANSBERT Director | 2021-09-01 | Sale | −790 | $29.47 | $23,281 | 258,970 | D: show line 5 in the form |
| GADICKE ANSBERT Director | 2021-09-01 | Sale | −5,714 | $29.47 | $168,392 | 7,752,573 | I: show line 6 in the form |
| GADICKE ANSBERT Director | 2021-09-02 | Sale | −2,178 | $29.46 | $64,164 | 256,792 | D: show line 7 in the form |
| GADICKE ANSBERT Director | 2021-09-02 | Sale | −15,757 | $29.46 | $464,201 | 7,736,816 | I: show line 8 in the form |
| Open-market sales · 27,669 sh · avg $29.50 · $816,352 | |||||||
Loading xslF345X03/doc4.xml…